Phcog.Net logo

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Article

    Naringenin Protects against 1‑Methyl‑4‑Phenylpyridinium‑ Induced Neuroinflammation and Resulting Reactive Oxygen Species Production in SH‑SY5Y Cell Line: An In vitro Model of Parkinson’s Disease

    Sugumar Mani2, Sathiya Sekar3, Saravana Babu Chidambaram4, Murugan Sevanan5 Corresponding author

    1. 1Research and Development Centre, Bharathiar University, Coimbatore, India.
    2. 2Department of Biotechnology, Dr. M. G. R. Educational and Research Institute University, Chennai, Tamil Nadu, India.
    3. 3Department of Pharmacology, JSS College of Pharmacy, JSS University, Mysore, Karnataka, India.
    4. 4Department of Biotechnology, Karunya Institute of Technology and Sciences, Coimbatore, India.

    CORRESPONDENCE

    Murugan Sevanan

    micromurugans@gmail.com

    Received: 26-01-2018; Revised: 16-05-2018.

    Volume 14, Issue 57s · pp. S458–S464 · PUBLISHED 10 September 2018 · DOI: 10.4103/pm.pm_23_18

    View on Pharmacogn. Mag. original site ↗

    ABSTRACT

    Background: Parkinson’s disease is a progressive neurodegenerative disorder which affects 1% of the population worldwide. It is well known that 1‑methyl‑4‑phenylpyridinium (MPP+) selectively and potentially inhibit Complex I of the mitochondrial electron transport chain. This inactivation leads to the generation of reactive oxygen species (ROS), which in turn damage neurons. In addition, neuroinflammation plays a major role in neurodegeneration processes. Objective: In the present study, the effect of naringenin (NGN), on MPP+‑induced neuroinflammation and ROS generation in SH‑SY5Y cells were investigated. Materials and Methods: Cells were pretreated with (0.1% dimethyl sulfoxide) or NGN (25, 50, and 100 µm/mL) for 24 h, and then induced with 1 mM MPP+ for 15 min. Following overnight incubation, cells were harvested for ROS staining, gene expression of apoptotic markers such as B‑cell lymphoma‑2 (Bcl‑2) and Bcl‑2‑associated X protein (Bax), inflammatory markers such as tumor necrosis factor‑alpha (TNF‑α), and nuclear factor‑κB (NF‑κB) and protein expression of neuronal markers such as dopamine transporter (DAT), tyrosine hydroxylase (TH), and α‑synuclein (SYN). Results: In this study, NGN exhibited oxidative protection by decreasing ROS generation which is evidenced through significant regulation of oxidative stress markers. Likewise, NGN decreased TNF‑α, Bax, and NF‑κB and increased Bcl‑2 gene expressions in MPP+‑induced SH‑SY5Y cells compared to normal SH‑SY5Y cells. Further, NGN significantly and dose‑dependently decreased SYN and increased DAT and TH levels in MPP+‑induced SH‑SY5Y cells in comparison to the normal cells. Conclusion: The results obtained from the present study revealed that NGN has the potential to encounter MPP+‑induced dopaminergic degeneration through regulating ROS generation and neuroinflammation.

    KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Mani, S., Sekar, S., Chidambaram, S. B., & Sevanan, M. (2018). Naringenin Protects against 1‑Methyl‑4‑Phenylpyridinium‑ Induced Neuroinflammation and Resulting Reactive Oxygen Species Production in SH‑SY5Y Cell Line: An In vitro Model of Parkinson’s Disease. Pharmacognosy Magazine, 14(57s), S458–S464. https://doi.org/10.4103/pm.pm_23_18